Moderna
MRNA
#1601
Rank
C$14.57 B
Marketcap
$37.71
Share price
-0.62%
Change (1 day)
-74.47%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$4.49 Billion

According to Moderna 's latest financial reports the company's total liabilities are C$4.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$4.65 B-23.31%
2023-12-31C$6.06 B-33.65%
2022-12-31C$9.13 B-31.86%
2021-12-31C$13.41 B120.24%
2020-12-31C$6.08 B1024.59%
2019-12-31C$0.54 B-7.96%
2018-12-31C$0.58 B1.91%
2017-12-31C$0.57 B-25.33%
2016-12-31C$0.77 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$10.76 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
C$97.99 B 2,082.47%๐Ÿ‡บ๐Ÿ‡ธ USA
C$60.71 M-98.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.78 B 28.75%๐Ÿ‡บ๐Ÿ‡ธ USA
C$80.51 B 1,693.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$1.32 B-70.45%๐Ÿ‡บ๐Ÿ‡ธ USA
C$150.47 B 3,251.25%๐Ÿ‡บ๐Ÿ‡ธ USA